Syndax Pharmaceuticals (SNDX) Depreciation & Amortization (CF) (2026)
Syndax Pharmaceuticals' (SNDX) quarterly Depreciation & Amortization (CF) came in at $4.0 million in Q1 2026.
Syndax Pharmaceuticals (SNDX) Depreciation & Amortization (CF) (2026) Analysis & Trends
Syndax Pharmaceuticals' Depreciation & Amortization (CF) history runs 1 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) changed N/A year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.0 million, down 25.0% from the prior year.
- Depreciation & Amortization (CF) held at $4.0 million in Q1 2026 per SNDX's latest filing.
- Across five years, Depreciation & Amortization (CF) topped out at $4.0 million in Q1 2026 and bottomed at $4.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |